Trading in the stock has been too thin lately to be able to absorb some waves of selling without moving the stock down a bit. I think the move down is directly related to the implied delays in producing new product because of the change in manufacturers. Medizone actually might have a patent and and FDA clearance before it has new product to sell. Official testing, it would make sense, also would be put on hold. 2014, anyone?